FdaApplication
NDA 216165
Identifiers
- fda_app_no: NDA216165
Properties
| Property | Value |
|---|---|
| applicant_name | ORCHID PHARMA LTD |
| application_type | NDA |
| approval_date | 2024-02-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EXBLIFEP | CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM | EQ 2GM BASE/VIAL;0.5GM/VIAL | POWDER;INTRAVENOUS |
1 product